REBECCA ANGELL: Open Payments
NPI 1952161903 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $85 |
| Veloxis Pharmaceuticals, Inc. | 1 | $31 |
| Davol Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: Ozempic, LIVTENCITY, ENVARSUS, XIFAXAN.
Industry payments across SC — which companies pay providers there.
